Clinical trial
Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving…
NCT00030758 · Anglo Celtic Cooperative Oncology Group, Other · Unknown status
Key facts
| NCT number | NCT00030758 |
|---|---|
| Title | Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer |
| Official title | G-CSF (Filgrastim) or Pegfilgrastim Secondary Prophylaxis In The Adjuvant Chemotherapy Of Early Breast Cancer |
| Lead sponsor | Anglo Celtic Cooperative Oncology Group, Other |
| Collaborators | Scottish Cancer Therapy Network |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Breast Cancer, Neutropenia |
| Intervention type | Biological |
| Interventions | filgrastim, pegfilgrastim |
| Enrollment | 816 |
| Start date | Oct 1, 2001 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 7, 2013 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: